$10.10
-0.1-0.98%
At Close: -
$10.10
00.00%
After Hours: 5:11 PM EDT
15 minutes delayed
Comments
Loading...
Vir Biotechnology
VIRNASDAQ
Vir Biotechnology (NASDAQ:VIR) Stock, Earnings Estimates, EPS, And Revenue
Vir Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$-0.890
Quarterly Revenue Estimate
$7.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$44M
Analyze the earnings history of Vir Biotechnology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology | -$1.45 | -$0.89 | — | — | $3.80M | $7.50M | — | — | 08/01/2024 | Get Alert |
| VIR | Vir Biotechnology | -$1.06 | -$1.05 | -$0.48 | 54.29% | $62.96M | — | $56.38M | — | 05/02/2024 | Get Alert |
| VIR | Vir Biotechnology | -$0.76 | -$1.01 | -$0.86 | 14.85% | $49.41M | $12.15M | $16.79M | 38.16% | 02/22/2024 | Get Alert |
| VIR | Vir Biotechnology | $1.30 | -$1.21 | -$1.22 | -0.83% | $374.56M | $10.24M | $2.64M | -74.23% | 11/02/2023 | Get Alert |
| VIR | Vir Biotechnology | -$0.58 | -$1.20 | -$1.45 | -20.83% | -$40.63M | $25.89M | $3.80M | -85.33% | 08/03/2023 | Get Alert |
| VIR | Vir Biotechnology | $3.85 | -$0.87 | -$1.06 | -21.84% | $1.23B | $51.53M | $62.96M | 22.18% | 05/04/2023 | Get Alert |
| VIR | Vir Biotechnology | $3.92 | -$0.39 | -$0.76 | -94.87% | $812.75M | $97.30M | $49.41M | -49.22% | 02/23/2023 | Get Alert |
| VIR | Vir Biotechnology | $0.82 | — | $1.30 | — | $103.60M | — | $374.56M | — | 11/03/2022 | Get Alert |
| VIR | Vir Biotechnology | $0.46 | -$0.61 | -$0.58 | 4.92% | $177.07M | — | -$40.63M | — | 08/09/2022 | Get Alert |
| VIR | Vir Biotechnology | -$1.32 | $3.78 | $3.85 | 1.85% | $1.98M | $836.97M | $1.23B | 47.20% | 05/05/2022 | Get Alert |
| VIR | Vir Biotechnology | -$0.83 | $3.04 | $3.92 | 28.95% | $1.73M | $622.90M | $812.75M | 30.48% | 02/24/2022 | Get Alert |
| VIR | Vir Biotechnology | -$0.67 | $0.02 | $0.82 | 4000.00% | $1.93M | $138.25M | $103.60M | -25.06% | 11/04/2021 | Get Alert |
| VIR | Vir Biotechnology | -$0.27 | -$0.48 | $0.46 | 195.83% | $66.99M | $84.56M | $177.07M | 109.40% | 08/05/2021 | Get Alert |
| VIR | Vir Biotechnology | -$0.71 | -$0.21 | -$1.32 | -528.57% | $5.72M | — | $1.98M | — | 05/06/2021 | Get Alert |
| VIR | Vir Biotechnology | -$0.71 | -$0.70 | -$0.83 | -18.57% | $980.00K | $4.81M | $1.73M | -63.95% | 02/25/2021 | Get Alert |
| VIR | Vir Biotechnology | -$4.60 | -$0.60 | -$0.67 | -11.67% | $1.40M | — | $1.93M | — | 11/10/2020 | Get Alert |
| VIR | Vir Biotechnology | — | -$0.62 | -$0.27 | 56.45% | $2.05M | — | $66.99M | — | 08/11/2020 | Get Alert |
| VIR | Vir Biotechnology | -$3.19 | -$0.53 | -$0.71 | -33.96% | $3.66M | $2.92M | $5.72M | 95.82% | 05/12/2020 | Get Alert |
| VIR | Vir Biotechnology | -$3.05 | — | -$0.71 | — | — | — | $980.00K | — | 03/26/2020 | Get Alert |
| VIR | Vir Biotechnology | -$4.16 | — | -$4.60 | — | $2.90M | — | $1.40M | — | 11/19/2019 | Get Alert |
Vir Biotechnology (VIR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.48 | $-1.05 | 54.3 % |
| Dec 2023 | 2024-02-22 | $-0.86 | $-1.01 | 14.8 % |
| Sep 2023 | 2023-11-02 | $-1.22 | $-1.21 | -0.83 % |
| Jun 2023 | 2023-08-03 | $-1.45 | $-1.20 | -20.8 % |
Vir Biotechnology (VIR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-22 | $16.79M | $12.15M | 38.2 % |
| Sep 2023 | 2023-11-02 | $2.64M | $10.24M | -74.2 % |
| Jun 2023 | 2023-08-03 | $3.80M | $25.89M | -85.3 % |
| Mar 2023 | 2023-05-04 | $62.96M | $51.53M | 22.2 % |
FAQ
When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?
Vir Biotechnology (VIR) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Vir Biotechnology (NASDAQ:VIR)?
The Actual EPS was $-0.48, which beat the estimate of $-1.05.
What were Vir Biotechnology’s (NASDAQ:VIR) revenues?
The Actual Revenue was $56.4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.